AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.550
+0.530 (51.96%)
At close: Oct 17, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $24.91 million as of October 17, 2025. Its market cap has increased by 410.60% in one year.
Market Cap
24.91M
Enterprise Value
24.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.55
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has increased from 20.42M to 24.91M, an increase of 22.00%. That is a compound annual growth rate of 5.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 24.91M | 390.08% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |